Four-Drug attack on blood cancer enters human trials
NCT ID NCT05392946
Summary
This study is testing a new combination of four drugs for people newly diagnosed with multiple myeloma, a cancer of plasma cells. The goal is to find the safest and most effective dose and see how well the drugs work together to control the cancer. Researchers will closely monitor patients for side effects and measure how deeply the treatment reduces the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CELL MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.